URGN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.10%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $442,667.92

UroGen Pharma Insider Trading History Chart

UroGen Pharma Share Price & Price History

^$16.35

▼ -0.01 (-0.06%)

As of 07/26/2024 01:00 AM ET

Days: 30 | 90 | 365

This student turned $1,300 into $45,000 in just 4 Months!

From Monument Traders Alliance | Ad

With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... In fact, it just detected a move happening this MONDAY.

See here to see the full details.

UroGen Pharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/10/2024	Mark Schoenberg	Insider	Sell	5,153	$13.08	$67,401.24	144,284
3/18/2024	Mark Schoenberg	Insider	Sell	12,000	$14.05	$168,600.00	139,437
1/31/2024	Jason Drew Smith	General Counsel	Sell	4,993	$15.74	$78,589.82	18,824
1/31/2024	Mark Schoenberg	Insider	Sell	3,789	$15.74	$59,638.86	149,423
8/31/2023	Jason Drew Smith	General Counsel	Sell	3,800	$18.01	$68,438.00	18,407
1/31/2023	Jason Drew Smith	General Counsel	Sell	1,636	$10.12	$16,556.32	12,600
1/31/2023	Mark Schoenberg	Insider	Sell	1,900	$10.12	$19,228.00	146,879
10/31/2022	Mark Schoenberg	Insider	Sell	258	$11.85	$3,057.30	23,950
8/1/2022	Mark Schoenberg	Insider	Sell	259	$7.81	$2,022.79	23,708
4/30/2022	Mark Schoenberg	Insider	Sell	254	$6.62	$1,681.48	23,467
1/31/2022	Elizabeth A. Barrett	CEO	Sell	8,195	$7.58	$62,118.10
1/31/2022	Jason Drew Smith	General Counsel	Sell	414	$7.58	$3,138.12
1/31/2022	Mark Schoenberg	Insider	Sell	1,374	$7.58	$10,414.92
1/31/2022	Molly Henderson	CFO	Sell	331	$7.58	$2,508.98
1/26/2022	Mark Schoenberg	Insider	Sell	111	$8.09	$897.99
1/4/2022	Elizabeth A. Barrett	CEO	Sell	46,968	$9.15	$429,757.20
11/30/2021	Jason Drew Smith	General Counsel	Sell	3,803	$12.03	$45,750.09
11/30/2021	Molly Henderson	CFO	Sell	2,587	$12.03	$31,121.61
11/18/2021	Mark Schoenberg	Insider	Buy	160	$13.10	$2,096.00
11/1/2021	Mark Schoenberg	Insider	Sell	258	$17.16	$4,427.28
10/27/2021	Mark Schoenberg	Insider	Sell	107	$16.32	$1,746.24
8/2/2021	Mark Schoenberg	Insider	Sell	243	$15.64	$3,800.52
7/26/2021	Mark Schoenberg	Insider	Sell	103	$15.30	$1,575.90

The next companies to potentially benefit thanks to Nvidia are …

From Weiss Ratings | Ad

Nvidia is pivoting to a new $1 trillion Superproject that could revolutionize the AI industry… again. And it’s enlisting a whole new set of partners.

Click here to learn more.

SEC Filings (Institutional Ownership Changes) for UroGen Pharma (NASDAQ:URGN)

91.29% of UroGen Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

UroGen Pharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
7/26/2024	ARK Investment Management LLC	151,781	$2.55M	0.0%	+3.7%	0.647%
7/26/2024	Bank of New York Mellon Corp	96,619	$1.62M	0.0%	+41.6%	0.412%
7/22/2024	Harel Insurance Investments & Financial Services Ltd.	463,565	$7.78M	0.1%	-31.2%	1.977%
7/17/2024	Oak Ridge Investments LLC	79,929	$1.34M	0.1%	+30.6%	0.341%
7/16/2024	Shikiar Asset Management Inc.	10,750	$0.18M	0.0%	-67.7%	0.046%
5/29/2024	Opaleye Management Inc.	270,000	$4.05M	0.9%	-15.6%	1.151%
5/17/2024	Tidal Investments LLC	28,320	$0.43M	0.0%	N/A	0.121%
5/16/2024	California State Teachers Retirement System	2,788	$42K	0.0%	-37.7%	0.012%
5/15/2024	Price T Rowe Associates Inc. MD	267,143	$4.01M	0.0%	N/A	1.139%
5/10/2024	Vanguard Group Inc.	194,966	$2.92M	0.0%	+14.3%	0.831%
5/1/2024	BNP Paribas Financial Markets	39,795	$0.60M	0.0%	+73.1%	0.170%
5/1/2024	Oak Ridge Investments LLC	61,204	$0.92M	0.1%	N/A	0.261%
4/30/2024	Harel Insurance Investments & Financial Services Ltd.	673,487	$10.10M	0.2%	-22.6%	2.872%
4/29/2024	China Universal Asset Management Co. Ltd.	5,903	$89K	0.0%	+65.1%	0.025%
3/5/2024	Wellington Management Group LLP	104,600	$1.57M	0.0%	+49.3%	0.446%
2/22/2024	Sierra Summit Advisors LLC	14,515	$0.22M	0.1%	N/A	0.062%
2/15/2024	Parkman Healthcare Partners LLC	175,500	$2.63M	0.4%	+20.8%	0.748%
2/14/2024	Superstring Capital Management LP	255,430	$3.83M	2.7%	N/A	1.089%
2/14/2024	RTW Investments LP	1,726,808	$25.90M	0.4%	+101.4%	7.364%
2/13/2024	Tower Research Capital LLC TRC	1,691	$25K	0.0%	-83.7%	0.007%
2/7/2024	Jump Financial LLC	33,320	$0.50M	0.0%	+12.6%	0.142%
2/7/2024	BNP Paribas Financial Markets	22,996	$0.35M	0.0%	+40.4%	0.098%
1/31/2024	Federated Hermes Inc.	11,709	$0.18M	0.0%	-10.8%	0.050%
1/26/2024	Cerity Partners LLC	125,226	$1.88M	0.0%	N/A	0.534%
1/25/2024	Allspring Global Investments Holdings LLC	4,955	$74K	0.0%	+31.6%	0.021%
1/24/2024	China Universal Asset Management Co. Ltd.	3,575	$54K	0.0%	+361.9%	0.015%
1/17/2024	ARK Investment Management LLC	161,525	$2.42M	0.0%	-25.0%	0.689%
1/12/2024	SG Americas Securities LLC	8,707	$0.13M	0.0%	N/A	0.037%
11/15/2023	Annandale Capital LLC	81,831	$1.15M	0.3%	-3.0%	0.349%
11/15/2023	RA Capital Management L.P.	1,483,697	$20.79M	0.4%	N/A	6.327%
11/15/2023	Laurion Capital Management LP	380,600	$5.33M	0.0%	+3.1%	1.623%
11/14/2023	Schonfeld Strategic Advisors LLC	130,200	$1.82M	0.0%	N/A	0.555%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	29,766	$0.42M	0.0%	+38.4%	0.127%
11/13/2023	EAM Investors LLC	170,523	$2.39M	0.5%	N/A	0.727%
11/13/2023	Federated Hermes Inc.	13,130	$0.18M	0.0%	N/A	0.056%
11/13/2023	Acadian Asset Management LLC	4,563	$63K	0.0%	-36.5%	0.019%
11/13/2023	Silverarc Capital Management LLC	508,883	$7.13M	2.2%	N/A	2.170%
11/7/2023	Jump Financial LLC	29,600	$0.42M	0.0%	N/A	0.126%
11/6/2023	Clal Insurance Enterprises Holdings Ltd	222,159	$3.11M	0.0%	-58.0%	0.947%
11/2/2023	Rice Hall James & Associates LLC	75,180	$1.05M	0.1%	-1.2%	0.321%
10/30/2023	Harel Insurance Investments & Financial Services Ltd.	870,194	$12.19M	0.2%	-15.1%	3.711%
10/30/2023	Meitav Investment House Ltd.	91,456	$1.30M	0.0%	-13.3%	0.390%
10/27/2023	Allspring Global Investments Holdings LLC	3,764	$53K	0.0%	N/A	0.016%
10/25/2023	Migdal Insurance & Financial Holdings Ltd.	648,302	$9.08M	0.2%	-7.2%	2.765%
10/24/2023	Bank of New York Mellon Corp	57,806	$0.81M	0.0%	+25.9%	0.247%
10/20/2023	Denali Advisors LLC	14,300	$0.20M	0.1%	-24.7%	0.061%
10/18/2023	ARK Investment Management LLC	215,272	$3.02M	0.0%	+6.6%	0.918%
9/21/2023	Barclays PLC	3,901	$41K	0.0%	-52.1%	0.017%
8/17/2023	Coastal Bridge Advisors LLC	37,732	$0.39M	0.1%	+2.0%	0.161%
8/16/2023	Stonepine Capital Management LLC	448,508	$4.64M	1.7%	-36.1%	1.913%
8/14/2023	Vivaldi Capital Management LP	11,500	$0.12M	0.0%	N/A	0.049%
8/14/2023	Partners Capital Investment Group LLP	15,384	$0.16M	0.0%	N/A	0.066%
8/11/2023	Stonepine Capital Management LLC	448,508	$4.64M	1.7%	-36.1%	1.972%
8/10/2023	Meitav Investment House Ltd.	105,512	$1.11M	0.0%	-1.6%	0.464%
8/8/2023	AlphaCentric Advisors LLC	152,500	$1.58M	0.9%	N/A	0.671%
8/7/2023	Acadian Asset Management LLC	7,187	$74K	0.0%	+57.5%	0.032%
8/4/2023	American International Group Inc.	9,417	$97K	0.0%	N/A	0.041%
7/31/2023	Menora Mivtachim Holdings LTD.	2,529,820	$26.18M	0.2%	-13.3%	11.125%
7/24/2023	Rice Hall James & Associates LLC	76,087	$0.79M	0.0%	+3.9%	0.335%
7/24/2023	Meitav Investment House Ltd.	105,512	$1.11M	0.0%	-1.6%	0.464%
7/18/2023	Denali Advisors LLC	19,000	$0.20M	0.1%	N/A	0.084%
7/10/2023	ARK Investment Management LLC	201,918	$2.09M	0.0%	-25.4%	0.888%
5/16/2023	Great Point Partners LLC	39,222	$0.36M	0.1%	-93.0%	0.172%
5/15/2023	Stonepine Capital Management LLC	701,535	$6.48M	2.2%	-46.2%	3.085%
5/11/2023	Meitav Investment House Ltd.	107,212	$1.25M	0.0%	-21.6%	0.471%
4/21/2023	Bender Robert & Associates	34,701	$0.32M	0.1%	N/A	0.153%
4/20/2023	Shikiar Asset Management Inc.	33,250	$0.31M	0.1%	N/A	0.146%
4/17/2023	ARK Investment Management LLC	270,746	$2.50M	0.0%	+37.5%	1.191%
2/14/2023	683 Capital Management LLC	22,604	$0.20M	0.0%	N/A	0.099%
2/13/2023	GSA Capital Partners LLP	31,046	$0.28M	0.0%	-36.9%	0.137%
2/10/2023	Opaleye Management Inc.	488,656	$4.33M	1.5%	+22.9%	2.149%
2/10/2023	Globeflex Capital L P	14,279	$0.13M	0.0%	N/A	0.063%
2/9/2023	Ethos Financial Group LLC	10,500	$93K	0.0%	N/A	0.046%
2/9/2023	Citigroup Inc.	54,615	$0.48M	0.0%	+16,400.0%	0.240%
2/8/2023	Oppenheimer & Co. Inc.	10,511	$93K	0.0%	N/A	0.046%
1/27/2023	Rice Hall James & Associates LLC	72,931	$0.65M	0.0%	-2.0%	0.321%
1/24/2023	ARK Investment Management LLC	196,938	$1.75M	0.0%	-30.1%	0.866%
11/14/2022	Ergoteles LLC	81,421	$0.68M	0.0%	-2.0%	0.358%
11/10/2022	Stonepine Capital Management LLC	1,124,220	$9.35M	4.2%	+1.2%	4.944%
11/1/2022	Rice Hall James & Associates LLC	74,431	$0.62M	0.0%	-32.6%	0.327%
10/17/2022	ARK Investment Management LLC	281,701	$2.34M	0.0%	-6.8%	1.239%
8/15/2022	Opaleye Management Inc.	238,670	$1.96M	0.9%	N/A	1.142%
8/15/2022	Laurion Capital Management LP	380,600	$3.12M	0.0%	N/A	1.821%
8/12/2022	Credit Suisse AG	1,060,010	$8.68M	0.0%	-2.4%	0.000%
8/12/2022	BBR Partners LLC	26,000	$0.21M	0.0%	-39.5%	0.124%
8/11/2022	Trexquant Investment LP	30,407	$0.25M	0.0%	+67.1%	0.000%
8/10/2022	Cerity Partners LLC	125,226	$1.03M	0.0%	-2.4%	0.599%
8/8/2022	Rice Hall James & Associates LLC	110,457	$0.91M	0.0%	+2.3%	0.529%
8/8/2022	Menora Mivtachim Holdings LTD.	2,949,489	$24.16M	0.4%	-0.1%	14.112%
7/19/2022	Bender Robert & Associates	41,131	$0.34M	0.1%	N/A	0.000%
7/11/2022	ARK Investment Management LLC	302,124	$1.61M	0.0%	-9.4%	1.446%
6/30/2022	Amalgamated Bank	2,960	$26K	0.0%	N/A	0.014%
5/12/2022	Annandale Capital LLC	84,331	$0.74M	0.3%	-2.2%	0.403%
5/11/2022	GSA Capital Partners LLP	57,224	$0.50M	0.1%	+46.5%	0.274%
5/9/2022	Meitav Dash Investments Ltd.	136,835	$1.19M	0.0%	-12.4%	0.655%
4/28/2022	Parallel Advisors LLC	3,047	$28K	0.0%	+6,383.0%	0.015%
4/19/2022	Denali Advisors LLC	4,100	$36K	0.0%	N/A	0.020%
4/19/2022	ARK Investment Management LLC	333,472	$2.91M	0.0%	+78.8%	1.596%
2/14/2022	Rice Hall James & Associates LLC	101,359	$0.96M	0.0%	-32.1%	0.485%
2/14/2022	GSA Capital Partners LLP	39,064	$0.37M	0.0%	+90.5%	0.187%

Data available starting January 2016

UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization of solutions for urothelial and specialty cancers. It offers RTGel, a novel proprietary polymeric biocompatible, reverse thermal gelation hydrogel technology to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102 for the treatment of several forms of non-muscle invasive urothelial cancer that include low-grade upper tract urothelial cancer and low-grade intermediate risk non-muscle invasive bladder cancer (NMIBC). It is also developing UGN-301 for the treatment of high-grade NMIBC. The company has license agreement with Agenus Inc. to develop, make, use, sell, import, and commercialize products of Agenus for the treatment of cancers of the urinary tract via intravesical delivery; strategic research collaboration agreement with MD Anderson focusing on the sequential use of UGN-201 and UGN-301 for the treatment of NMIBC; and licensing and supply agreement with medac Gesellschaft für klinische Spezialpräparate m.b.H. to develop UGN-103 in low-grade intermediate risk NMIBC and UGN-104 in low-grade upper tract urothelial carcinoma. UroGen Pharma Ltd. was incorporated in 2004 and is based in Princeton, New Jersey.

Today's Range

Now: $16.35

$15.99

$16.78

50 Day Range

MA: $15.40

$12.72

$19.20

52 Week Range

Now: $16.35

$8.77

$24.13

Volume

314,828 shs

Average Volume

470,223 shs

Market Capitalization

$383.41 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.12

Who are the company insiders with the largest holdings of UroGen Pharma?: UroGen Pharma's top insider investors include:
Mark Schoenberg (Insider)
Jason Drew Smith (General Counsel)
Learn More about top insider investors at UroGen Pharma.
Who are the major institutional investors of UroGen Pharma?: UroGen Pharma's top institutional investors include:
Harel Insurance Investments & Financial Services Ltd. — 1.98%
ARK Investment Management LLC — 0.65%
Bank of New York Mellon Corp — 0.41%
Oak Ridge Investments LLC — 0.34%
Shikiar Asset Management Inc. — 0.05%
Learn More about top institutional investors of UroGen Pharma stock.
Which institutional investors are selling UroGen Pharma stock?: In the last quarter, URGN stock was sold by these institutional investors:
Harel Insurance Investments & Financial Services Ltd.
Shikiar Asset Management Inc.
Within the previous year, company insiders that have sold UroGen Pharma company stock include:
Mark Schoenberg (Insider)
Jason Drew Smith (General Counsel)
Learn More investors selling UroGen Pharma stock.
Which institutional investors are buying UroGen Pharma stock?: Within the last quarter, URGN stock was purchased by institutional investors including:
Bank of New York Mellon Corp
Oak Ridge Investments LLC
ARK Investment Management LLC